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Abstract
Background: Persistent non-participation of children in mass drug administration (MDAs) for trachoma may reduce
program impact. Risk factors that identify families where participation is a problem or program characteristics that foster
non-participation are poorly understood. We examined risk factors for households with at least one child who did not
participate in two MDAs compared to households where all children participated in both MDAs.
Methods/Principal Findings: We conducted a case control study in 28 Tanzanian communities. Cases included all 152
households with at least one child who did not participate in the 2008 and 2009 MDAs with azithromycin. Controls
consisted of a random sample of 460 households where all children participated in both MDAs. A questionnaire was asked
of all families. Random-intercept logistic regression models were used to estimate odds ratios (ORs) and 95% confidence
intervals (CIs), control for clustering, and adjust for community size. In total, 140 case households and 452 control
households were included in the analyses. Compared to controls, guardians in case households had higher odds of
reporting excellent health (OR 4.12 (CI 95% 1.57–10.86)), reporting a burden due to family health (OR 3.15 (95% CI 1.35–
7.35)), reduced ability to rely on others for assistance (OR 1.66 (95% CI 1.01–2.75)), being in a two (versus five) days
distribution program (OR 3.31 (95% CI 1.68–6.50)) and living in a community with ,2 community treatment assistants
(CTAs)/1000 residents (OR 2.07 (95% CI 1.04–4.12). Furthermore, case households were more likely to have more children,
younger guardians, unfamiliarity with CTAs, and CTAs with more travel time to their assigned households (p-values,0.05).
Conclusions/Significance: Compared to full participation households, households with persistent non-participation had a
higher burden of familial responsibility and seemed less connected in the community. Additional distribution days and
lessening CTAs’ travel time to their furthest assigned households may prevent non-participation.
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Introduction
Trachoma is a leading cause of preventable blindness [1].
Nearly 41 million individuals across the globe are estimated to
suffer from active trachoma [2]. Of these, the majority are
children from impoverished regions [3,4]. Virtually all trachoma
burden is either concentrated in rural Africa, particularly Ethiopia,
Kenya, Niger, Sudan and Tanzania, or parts of Asia [5].
The World Health Organization (WHO) advocates mass drug
administration (MDA) in eligible communities as a key component
of the Surgery, Antibiotics, Face-washing, Environmental change
(SAFE) strategy for treating and preventing trachoma. When a
community’s prevalence of follicular trachoma (TF) is greater than
10% in children less than age ten years, the WHO supports at least
three annual mass drug administrations (MDAs). [6]. In Tanzania,
azithromycin is provided to the Ministry of Health free of charge
through a donation program from Pfizer Inc and International
Trachoma Initiative. For each resident over age one year, a single
oral dose of azithromycin at 20 mg/kg up to 1 gram, is
recommended, and infants one year and younger are treated with
topical tetracycline. Data suggest that endemic communities often
require multiple rounds of mass treatment for reducing the
prevalence of trachoma [7,8]. Programs aim for antibiotic
coverage goals of at least 80% or more in the entire community
[6].
Low treatment coverage with antibiotics in children under ten
years is problematic. Young children are a high-risk group for
trachoma and infection [9]. Extensive child non-participation in
community mass treatments may reduce the effectiveness of
trachoma control programs. Untreated children are likely to
spread trachoma to other household members and subsequently
more individuals in the community [10,11]. Furthermore,
programs squander resources in having to execute additional
MDAs when the community treatment coverage is low. Given the
WHO recommendations for multiple MDAs in trachoma-endemic
communities, characterizing the households with children who
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or more children who never participate in MDAs may help
programs develop strategies for avoiding persistent child non-
participation.
This study aimed to examine the predisposing and resource risk
factors for Tanzanian households with children who never
participated in two treatment rounds compared to households
where all children participated.
Methods
The Johns Hopkins Medical Institutional Review Board and the
National Institute for Medical Research in Tanzania approved
the study protocol. All guardians provided written consent for the
study.
Study Location
We conducted the study in the Kongwa district of Tanzania.
Located in the Dodoma region of Tanzania, approximately
250,000 people were residents of Kongwa in 2002 [12]. This study
was nested in a larger study [13] of 32 communities which were
randomly picked from a list of all communities who met the
following criteria: Local government leaders had to provide
consent (all communities who were approached did provide
consent), and the best-estimated prevalence of trachoma in 2007
was greater than 20% for each community. Due to timing of the
MDA, this study was carried out in 28 of the 32 communities.
Census
As described in [13], prior to each round of MDA, trained
research staff completed a census of all households in each
community by going to each household and enumerating the
residents. Demographic information on each household member
was collected at this time. The data were used to develop
treatment log books for MDAs. This level of precision was
required as part of our research program. In 2008 and 2009, each
community received mass treatment.
Training of Community Treatment Assistants
The Kongwa Trachoma Project (KTP) team trained a group of
CTAs, approximately two to six individuals per 1500 persons in
each community. Community leaders assisted in identifying
persons in the community who would be trusted to deliver
MDA, and the KTP staff interviewed and ultimately chose the
CTAs. The CTAs received a one-day program discussing
trachoma, the disease and consequences, the SAFE strategy,
details on azithromycin and possible side effects and how to record
them, instructions on how to administer azithromycin by weight to
children under one year, and using the height sticks for children
greater than one year. If there was doubt as to age one year or less,
and the child was below the smallest level of the height stick, the
children were weighed. CTAs delivered MDA in their neighbor-
hoods, as would be done in the national Program. We received
ethical approval to treat children from one year to 6 months with
oral azithromycin, 20 mg/kg, and those under 6 months were
treated with topical tetracycline. In addition, the CTAs received
training in recording the observed treatment on treatment logs.
They also received modest training in asking about vision
problems and recognizing trichiasis, in order to keep a record of
all persons in the village who had need of further eye care and
surgery.
In other districts in Tanzania, there may be modest differences
in approaches to MDA; in general the districts provide training to
village health workers and community treatment assistants (CTAs)
on use of height sticks for treating all residents, with those who are
adults (not defined further) receiving 1 gm. Treatment is recorded
in log books, and estimated village populations are used to monitor
coverage. Two days at least are allotted for MDA, and the CTAs
originally, but not since 2006, received monetary incentives.
Mass Treatment
All communities in the Kongwa district were mass treated on a
rolling basis over a period from June to November 2008, and
again over the same months in 2009, including communities not in
the study. Communities in our study, as part of the larger study
were randomly allocated to either a two-day or a five-day
distribution program, which began after the census and surveys for
the larger study in each community. The June to November time
period was chosen because it was after the planting harvest so
guardians would be home for mass treatment and to be
interviewed. Community treatment assistants offered each resident
over six months a single oral dose of azithromycin, 20 mg/kg up
to one gram, irrespective of disease status. Oral treatment was
directly observed and recorded in a logbook based on the
household census. To children less than six months, CTAs gave
guardians tetracycline eye ointment to administer topically for four
to six weeks. The first dose was instilled but subsequent doses were
not directly observed. All communities aimed for treatment
coverage greater than or equal to 80% in children under age
ten and those in the five day distribution arm were allowed 3 extra
treatment days to achieve 90% coverage or greater. At least one
member of the KTP staff was in the community each day of
MDA, meeting with the CTA and reviewing performance.
Each CTA was assigned a certain number of households for
which they were responsible. The CTAs administered treatment to
residents at a central location, and if necessary, at the household.
CTAs were instructed to review their log books after the first day
and if necessary schedule a second central location site or go to
each non-participant person’s home if necessary and treat them
directly. The choice of options was up to the individual CTA, but
the goal for the entire community was to achieve at least 80%.
Author Summary
The World Health Organization advocates at least three
mass drug administrations (MDAs) with antibiotics when
the prevalence of follicular trachoma (TF) is greater than
10% in children under age ten. Full child participation is
necessary for maximizing the impact of trachoma control
programs. The present paper identifies guardian, house-
hold, and program risk factors for households with a child
who never participated in two annual rounds of MDAs
with azithromycin. In comparison to households with full
child participation, guardians with at least one child who
never participated had a higher burden of familial
responsibility, as represented by reporting ill family
members, more children, and were younger in age. In
addition, guardians of persistent non-participants seemed
less well connected in the community, in terms of reliance
on others and not knowing who their assigned community
treatment assistants (CTAs) were. These guardians were
assigned to CTAs who had a wide geographic dispersion of
their assigned households. By developing programs with
local groups to find and encourage participation in at-risk
households, program managers may have the greatest
impact on preventing persistent child non-participation.
Increasing the number of distribution days and reducing
CTAs’ travel time may further prevent non-participation.
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customized databases.
Treatment Verification
Standard quality control measures were used to verify coverage.
KTP staff went back to a random sample of 5 households per
CTA to verify treatment status of all household members. If
treatment as recorded in the CTA treatment log was at least 70%
concordant with treatment as stated by the family for each
member, the CTAs received a small monetary incentive (1,000
TSH or $0.80) per day of work. No CTA was found to be under-
performing by this criteria.
2009 CTA survey
Data were not routinely collected on characteristics of the CTA.
Therefore, for this study each CTA completed a survey on their
age, sex and marital status. We also asked about past work
experience (e.g. any past MDA experience).
Identification of Study Population
We used the census and MDA data to identify case and control
households with children between six months and nine years at the
2008 census. Our criteria required children to be residents in the
households from the 2008 census to the 2009 MDA. Case
households included at least one child, between six months to nine
years old at the 2008 census, who did not participate inthe 2008 and
2009 MDAs. Control households contained children from six
months to nine years at the 2008 census who were treated at both
MDAs. We did not match or restrict criteria for controls. We
interviewed the guardianofthe chlld,defined as eitherthemotheror
father, or if neither was serving as the guardian, the person in the
household who self reported being the guardian. Interviewers
surveyed fathers with more than one household in the community
onlyonce,andexcluded3fatherswhohadalreadybeeninterviewed.
Our sample size calculation included the following assumptions:
alpha=0.02, beta=0.20, 2:1 control to case ratio, prevalence of
30% for most risk factors,and odds ratio of 2.0.We conducted a
Bonferroni adjustment for 3 comparisons of the same set of risk
factors for this and a companion paper on change in participation.
If no correction were applied, we would have had a chance of
0.1426 (14.26%) of finding one or more significant differences in 3
tests. To get an alpha level of 0.05, we lowered the alpha for each
test to 0.01667,0.017. Assuming a non-response/ineligible rate of
15%, the necessary sample size was 330 control households and
165 case households. The adjustment was to make sure we had the
correct sample, size, and that we could report at alpha=0.5, Using
simple random sampling, we enrolled a random sample of 460
control households from a larger sample of 5375 control
households and all households identified as having at least one
child who was a persistent non-participant in MDA. We attempted
to contact every case and control household in the 28
communities.
Data Collection
Fieldwork. We trained local field interviewers to administer
the risk factor survey and data clerks to enter completed surveys in
customized Access databases. At least one to two days prior to data
collection, we met with community leaders, explained the study
purpose, and requested permission to conduct the study in their
community. After obtaining approval, field interviewers surveyed
guardians in their homes up to six weeks after the 2009 MDA.
Data collection and entry for the risk factor questionnaire took
place from mid-July to late October 2009.
Risk factors. A formal literature review following extensive
search guidelines developed by a senior librarian and the first
author was carried out to identify factors associated with MDA for
trachoma, lymphatic filariasis, onchocerciasis, and schistosomiasis
(these were chosen because they are neglected tropical diseases
where MDA is part of the control strategy). The literature resulted
in the identification of predisposing and resource factors associated
with participation in mass treatment programs. We classified
potential risk factors related to the guardian, household, and MDA
program as either predisposing or resource factors according to the
Andersen Behavioral Model of Health Service Use [14].
Predisposing risk factors were characteristics that predisposed a
household not to seek mass treatment (such as guardian age or
gender). Conversely, resources risk factors were lack of assets that
promoted mass treatment participation.
Our review found the following predisposing risk factors for
guardians:male gender, older age, no formal education (defined as
self report of absence of schooling), minority ethnic group
membership (defined as self report of tribe other than Gogo or
Kaguru), self rated perception of health as excellent (compared to
good, fair or poor) the week before the MDA, short-term resident
(less than ten years living in the community) and not born in
community, non-attendance at the MDA promotional meeting,
and recently seeking a traditional healer in the month before the
2009 MDA.
Increasing numbers of children in household, report of ill family
members in household (family health burden), household history
of child adverse events in 2008 MDA, no perceived trachoma risk
in the household were predisposing risk factors for households. We
included ‘‘traditional belief’’, defined as self report of possession by
a malevolent spirit (mashetani), as a possible reason for non-
participation. Possession with spirits is a common belief in
Tanzania, and persons so possessed are instructed by local healers
not to mix local medicines with western medicines [15]. Past MDA
qualitative reports indicated possession by a malevolent spirit was
a reason for not taking azithromycin; thus, we included a question
on ever being possessed by a malevolent spirit as a potential
predisposing household risk factor. The categories consisted of
child and guardian ever possessed, only child ever possessed, only
guardian ever possessed, and child and guardian never possessed.
As predisposing factors for programs, we investigated the
following: male CTA, guardian’s perception of poor CTA
performance (defined as rating the CTAs’ ability to get
azithromycin to the families in the community), longer travel time
from the household to the central distribution site, longer travel
time between the CTA’s household and the furthest assigned
household in community and lack of familiarity with his/her
assigned CTAs.
We examined resource risk factors for guardians and programs.
Resource risk factors for guardians included levels of social
interaction, as assessed using a standard questionnaire for contact
with family and friends; this was coded as level of contact with
other family members (not living in the house but in the
community) with everyday versus no/little/some contact. Simi-
larly, for contact with friends, the results were coded as everyday
versus no/little/some contact with friends in community. We also
evaluated social reliance, with standard questions on inability to
rely on others for money and shelter. We categorized inability to
rely on others (who do not live with them) for money and shelter:
low was no one to rely on for money and shelter, moderate was
either someone to rely on for money or someone to rely on for
shelter, but not both, and high was someone to rely on for both
money and shelter. Finally, the resource risk factors for programs
were two (versus five) days distribution and less than two CTAs per
Non-Participation in Mass Treatment for Trachoma
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items from other surveys used in Tanzania, and our questionnaire
was vetted through two focus group sessions, using residents from
villages not included in the study. Residents from a nearby village
in the Kongwa district that did not participate in the study
participated in the pilot study, and provided final feed back on the
risk factor survey.
There were four sources of risk factors information: the risk
factor survey, the MDA log books, the CTA survey and the 2008
census.
Data Analysis
The primary outcome of interest was a family where at least one
child was a continuous non-participant in MDA. We conducted
exploratory data analyses, using Pearson’s chi-square tests of
independent proportions for nominal data, Mann-Whitney tests
for ordinal data and t-tests for continuous data. Backwards
stepwise logistic regression models assisted in the identification of
risk factors with a p-value less than 0.10. One by one, we
incorporated each significant risk factor into a random-intercept
logistic regression model to evaluate changes in odds ratios and
95% confidence intervals (CIs) and adjust for clustering at the
community level. We controlled for community size (small
size=bottom 33% communities, medium size=middle 33%
communities and large size=top 34% communities) as a
confounder and selected the model with the lowest Akaike’s
information criterion (AIC). We hypothesized that households
where all children never participated were different from
household where some children never participated. Thus, we
performed subgroup analyses with a multinomial model compar-
ing risk factors between: 1) households where every child was a
persistent non-participant in both MDAs, 2) households in which
some children were persistent non-participants, and 3) households
with all children participating in both MDAs. Using this model,
the relative risk ratio (RRR) represents the change in the odds of
being in the case subgroup versus the control group, where the
model can simultaneously estimate the RRR for each case sub-
group associated with a one unit change in the independent
variable. All analyses were run in STATA ver. 11 (Stata Corp,
College Station, Texas).
Results
In this area, our program offered mass treatment twice, and
households with children who never participated in two rounds
was quite low, occurring in 2% of 6727 households.
Our study contacted 612 households, 152 with at least one child
who was a persistent non-participant and 460 where all children
participated in both rounds. According to our 2008 census,
contacted households had 2,129 children. The mean community
size in the case control study was 1,685 people (standard
deviation=482). Community populations ranged from 750 to
2611 residents in 2008. The mean number of persons per
household was five, and the average number of persons under age
ten was two children. Of the 612 households, 596 (97%)
households completed the risk factor survey.
Twenty households of the original 612 were not included in the
analyses. Three households were ineligible (2 in case households, 1
in the control households). Thirteen households did not respond
(10 case households, and 3 control households),, In four control
households, we could not be certain if treatment had taken place
for each child following treatment verification.. We had no missing
information on mass treatment for any child in the surveyed
households.(Figure 1) Our study observed no differences in CTA
characteristics and guardian demographics between non-response
and response households (data not shown).
Some household and program predisposing risk factors were
significantly associated with being a household with at least one
persistent non-participant (Tables 1 and 2). The risk increased
with each additional child in the household of being a household
with a persistent non-participant (p,.01). This remained signif-
icant after adjusting for other factors (Odds Ratio (OR)=1.70,
95% Confidence Interval (CI)=1.39–2.08) (Table 3) Guardians in
households with a persistent child non-participant had more than
a tenfold odds of not rating the assigned CTAs performance
(p=0.02), but this was also correlated with not knowing their
assigned CTAs which was also significantly associated with
persistent non-participation (p,0.01). Adjusting for other factors,
incorrectly naming or being unable to name their assigned CTAs
was associated with an increased risk of persistent non-participa-
tion (OR=1.99 (95% CI=1.16–3.06) and 5.17 (95% CI=2.17–
12.32), respectively). Compared to households with full child
participation, households with persistent child non-participation
were more likely to be assigned to CTAs living more than one
hour from their furthest assigned household in the community.
This relationship persisted after adjustment for multiple factors
(OR=2.58, 95% CI=1.22–5.44).
A numberofguardian and householdpredisposingfactorshadno
association with household with persistentchild non-participation in
simple bivariable analyses. Guardian’s age, education, perceived
health, length of residency, gender, traditional healer use, ethnic
group, and attendance at a promotional meeting for mass treatment
did not predispose a household to persistent child non-participation.
We found no association between persistent non-participation and
household predisposing risk factors: reported family health
problems, household history of adverse events during the 2008
MDA, and familial possession with malevolent spirits.
Our study found associations between households with a child
who never participated and guardian and program resource risk
factors (Table 2). Households with a persistent non-participant had
low score of social reliance (not being able to ask anyone for
money or for a place to live). Compared to households with full
child participation, households with persistent child non-partici-
pation were more likely to live in a community with a two (versus
five) days distribution strategy, and more than a threefold odds of
being in a community with less than two CTAs per 1000 residents
(p-value,0.01). These factors remained significant when adjusted
for multiple factors (Table 3).
After controlling for community size, clustering, and the other
variables, our final model identified several independent predis-
posing and resource risk factors for persistent child non-
participation (Table 3). Predisposing factors included younger
age and perceived excellent health the week of the 2009 MDA,
familial health burden and increasing numbers of children in the
family. Resource risk factors included guardians with low scores
for social reliance, increased travel time from the assigned CTA’s
household to the furthest household in the community, less than
two CTAs per 1000 residents in the community, and a two days
(versus five) days distribution strategy.
Our case and control guardians had some similarities and
differences in their response to the general question of the primary
reason why parents in the community did not bring their children
for treatment (Table 4). In case households, the two most common
reasons were travel outside the community during mass treatment
and perceived negative side effects from drugs. Control households
reported negative side effects from drugs as well, but also felt that
general lack of knowledge (stated as ‘‘ignorance’’) and lack of
Non-Participation in Mass Treatment for Trachoma
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participation.
Of the 140 households that completed the risk factor survey, 54
(40%) were households in which all children never participated in
both MDAs. The remaining 86 (60%) households contained some
children who had participated in one or both rounds as well
children who were non-participants in both rounds. We
hypothesized differences between these two subgroups, compared
to households where all children participated. Common factors for
both groups were program predisposing and resource factors:
being in a two days distribution program and not being familiar
with any assigned CTA (Table 5). However, compared to
households with full child participation, households where all
children never participated both times had healthier guardians,
expressed a family health burden, and were in a program with less
than two CTAs per 1000 residents.
Households where some children participated and others did
not in both rounds had other risk factors. In comparison to
households with all children treated both times, each additional
child in the household increased the risk of having a household
where some (but not all) children were persistent non-participants.
In addition, these households had younger guardians, and were
assigned CTAs living more than one hour from the furthest
assigned household.
Figure 1. Flow Diagram of participation of case and control households.
doi:10.1371/journal.pntd.0001576.g001
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Cases (n=140) Controls (n=452) OR* P-value
%%
Guardian predisposing factors
Each one year decrease in guardian age (mean age shown) (34) (35) 1.02 0.08
Guardian never (versus ever) educated 48 45 0.86 0.49
Guardian’s health is excellent (versus fair and poor) 92 83 2.24 0.03
Guardian residency
Community born 53 54 1.00
Long-term resident, born outside the community 11 22 0.50 0.05
Short-term resident, born outside the community 36 24 1.54 0.08
Male (versus female) guardian 16 10 1.59 0.14
Traditional healer use
Did seek healer traditional healer 4 7 1.00
Did not seek traditional healer 96 93 2.40 0.10
Guardian ethnic group
Gogo 42 47 1.00
Kaguru 43 43 0.70 0.21
Other 15 10 1.82 0.09
Guardian attended promotional meeting
Guardian attended a meeting 14 21 1.00
Guardian did not attend a meeting 86 79 1.31 0.36
Do not know if attended meeting 0 0.2 NA NA
Household predisposing factors
Each additional child in the household at 2008
census (mean number of children shown)
(3) (2) 1.66 ,0.01
No (versus any) child had itchy or swollen eyes in household 20 16 1.50 0.13
Family possessed with malevolent spirits (mashetani)
Child and guardian or child only 3 4 1.00
Guardian only 11 16 0.90 0.86
Not child and not guardian 86 80 1.33 0.61
Family health problems affected (versus did not affect)
guardian’s ability to perform extra tasks
14 13 1.20 0.57
No (versus any) child with adverse event in 2008 MDA 96 95 1.16 0.77
Program predisposing factors
Travel time from guardian’s household to central
distribution site&
0–30 minutes 84 89 1.00
31–60 minutes 11 8 1.64 0.19
More than 60 minutes 5 3 2.30 0.15
CTA familiarity
Correctly identifying CTA 39 57 1.00
Incorrectly identifying CTA 47 39 1.54 0.06
Do not know any CTA 14 4 4.71 ,0.01
Perception of CTA performance
Excellent or good 94 98 1.00
Poor or fair 2 2 1.03 0.97
Do not know 4 0.4 10.98 0.02
Male (versus female) CTA 52 52 1.17 0.48
Travel time from CTA’s household to furthest
assigned household in community
Less than 30 minutes 29 45 1.00
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We have previously shown that treatment non-participation
clusters within families in these communities [16]. This study
builds on our previous research and suggests that several
predisposing and resource factors at the guardian, household,
and program level are associated with child non-participation in
families. Findings of equal importance are some predisposing and
resource factors which did not seem to be related to persistent non-
participation in children. These are discussed below.
Guardians
Guardians exert a strong influence on their children’s
healthcare. It is therefore important to ensure that trachoma
control programs providing mass treatment address guardian
concerns and barriers. Identifying guardian characteristics of
households’ with persistent child non-participation may help
programs target households at-risk.
Among the possible guardian predisposing and resource risk
factors studied, younger guardian age, perceived excellent health,
and decreased ability to rely on others were useful markers of
households with persistent child non-participation. Similar to our
study, other child health services have found younger guardian age
is a risk factor for lower use of child health services [17]. This
variable was more important for households where not all children
were persistent non participants, which suggests the difficulty
young guardians have in bringing all children to MDA.
Guardians in households with persistent child non-participation
perceived their health as better during the week of mass treatment
compared to guardians in households with full child participation.
This result is comparable to another program that found people
who were healthy tended to not participate in mass treatment [18].
Guardians in households with full child participation may have
been less healthy and thus more likely to take their children for
MDA because they themselves also wanted to be treated. Also,
those who report being healthy were more likely to be guardians of
Table 1. Cont.
Cases (n=140) Controls (n=452) OR* P-value
%%
31–60 minutes 41 26 2.03 0.05
More than 60 minutes 29 29 2.18 0.04
CTA: Community treatment assistant.
MDA: Mass drug administration.
OR: Odds ratio.
*Odds ratios accounted for clustering within communities using random-intercept logistic regression.
NA: Numbers were too small to display odds ratios.
&The sample size number for this odds ratio reduced to 558 households. The CTA visited twenty-one control households and ten case households. Two case households
and one control household did not know the time.
doi:10.1371/journal.pntd.0001576.t001
Table 2. Resource factors for persistent child non-participant (Case group) versus full child participation (Control group).
Cases (n=140) Controls (n=452) OR* P-value
%%
Guardian resource factors
Frequency of contact with other family
Every day 42 42 1.00
Not every day 40 47 1.00 0.99
Do not have other family 18 11 1.83 0.07
Frequency of contact with friends
Every day 73 82 1.00
Not every day or do not have friends 27 18 1.65 0.05
Social reliance
High ability to rely on someone for money and shelter 26 37 1.00
Moderate ability to rely on someone for money and shelter 55 52 1.57 0.07
Low ability to rely on someone for money and shelter 19 11 2.13 0.02
Program resource factors
Two (versus five) days distribution 69 46 4.63 ,0.01
Less than 2 (versus 2 or more) CTAs per 1,000 residents 58 28 3.99 ,0.01
CTA: Community treatment assistant.
OR: Odds ratio.
*Odds ratios accounted for clustering within communities using random-intercept logistic regression.
doi:10.1371/journal.pntd.0001576.t002
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there was no perceived need for treatment or low priority was
given to participation. We found no difference between the case
and control households in perceived risk of trachoma in their
children, suggesting that general self-perception of health may be
more important than messages about trachoma.
Social reliance or the ability to rely on other individuals for
money or a place to live was an important guardian resource that
households with persistent child non-participation lacked. That
ability to rely on others is a key part of kinship systems, systems
that continue to thrive in Tanzania [19]. A high degree of
reciprocal exchange of goods and services in these systems exists,
and it is through this sharing of resources that the groups thrive.
Social networks provide an informal social security; research has
demonstrated a positive association between larger strong social
networks and well-being in low-income countries [19]. Guardians
who could not rely on others for money or shelter were likely not
as deeply supported as were other guardians in the community.
The association was strongest for guardians of households where at
least some children participated in one or both rounds. For these
guardians, getting help transporting all their children to the central
distribution site for treatment in both MDAs was possibly more
difficult. Thus, distribution strategies that target marginalized
households - guardians who cannot rely on others for money or a
Table 4. Primary reason provided for non-participation in MDA by household participation status.*
Case households with persistent non-
participants
n=140
Control households with full child
participation
n=452
Reasons n (%) n (%)
Traveling 33 (24) 35 (8)
Negative effects from drug 32 (23) 125 (28)
Lack of education/Ignorance 13 (9) 65 (14)
No notice of treatment 6 (4) 30 (7)
Did not have eye problems 5 (4) 24 (5)
Other 11 (8) 21 (5)
Do not know 40 (29) 152 (34)
*The chi-square comparison p-value is 0.00.
doi:10.1371/journal.pntd.0001576.t004
Table 3. Model of risk factors for households with at least one persistent child non-participant.
Risk factors OR* 95% CI P-value
Reliance on others for money and shelter
High ability to rely on someone for money and shelter 1.00
Moderate ability to rely on someone for money and shelter 1.66 (1.01–2.75) 0.05
Low ability to rely on someone for money and shelter 1.99 (0.98–4.04) 0.06
Guardian age (per one year decrease) 1.02 (1.00–1.04) 0.04
Guardian health reported excellent (versus poor/fair) 4.12 (1.57–10.86) ,0.01
Family health burden (versus no burden) 3.15 (1.35–7.35) 0.01
Each additional child in the household 1.70 (1.39–2.08) ,0.001
Travel time from CTA’s household to furthest assigned household in community
Less than 30 minutes 1.00
31–60 minutes 1.52 (0.80–2.91) 0.20
More than 60 minutes 2.58 (1.22–5.44) 0.01
Two (versus five) days distribution 3.31 (1.68–6.50) ,0.01
Less (versus more) than 2 CTAs per 1,000 residents 2.07 (1.04–4.12) 0.04
Familiarity with CTA
Correctly identified at least one CTA 1.00
Incorrectly identified all CTAs named 1.88 (1.16–3.06) 0.01
Did not know any CTAs 5.17 (2.17–12.32) ,0.01
CI: Confidence interval.
CTA: Community treatment assistant.
OR: Odds ratio.
*Odds ratios were adjusted for community size and clustering at community level using random-intercept logistic regression.
doi:10.1371/journal.pntd.0001576.t003
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children for treatment as a way of keeping them and their family
healthy, may prevent persistent child non-participation.
Household
An understanding of household barriers may also assist programs
in recognizing households at-risk for persistent child non-participa-
tion. We found that reported family health problems severe enough
to interfere with daily tasks was a strong risk factor for households
with persistent child non-participation. This was especially the case
for households where no children participated. The family health
burden originated from family members (e.g. husband, grandmoth-
er) not from the guardian, as the guardian perceived him/herself as
healthy. Research has linked a stressed guardian to lower use of
childhealthservices[20].Guardiansunderstress,potentially caused
by a health burden within the family, must contend with many
hardships that compete with MDA.
Multiple young children in the household were a characteristic
of households with some children who never participated. Our
results were consistent with a previous study that examined
households factors associated with azithromycin coverage after a
single round [21], which also found that having more children
residing in the household adversely influenced household cover-
age. Guardians may find the logistics of bringing all children in the
household to a treatment center difficult if the number in a
household is large. Additional studies have verified that mothers
with multiple children are at high risk for having under-vaccinated
children and using fewer primary care services for children
[20,22,23]. As noted, these households tend to have younger
guardians with less ability to rely on others as well, providing an
image of over-burdened young guardians who tend not to
participate.
Social mobilization programs, involving local groups, have been
useful in targeting marginalized households at-risk for non-
participation in child health services [24]. In Dhaka, Bangladesh,
an intervention package including a supportive group for social
mobilization was valuable in moving from 43% children fully
immunized to 99% children fully immunized. Since we now know
characteristics of households with children who persistently do not
participate, we could use a similar strategy to identify and assist
households with many young children who have less ability to rely
on others, or describe having a family member with an illness.
Program
Modifying some treatment program characteristics related to
visibility, access and organization might reduce persistent child
non-participation. Inability to name the CTAs was one program
factor in our study that could be targeted. Other mass treatment
programs have observed non-familiarity with CTAs as a risk factor
for individual non-participation [25,26]. In these MDAs, commu-
nity members did not trust CTAs because they were unknown and
not part of their community. However, as most CTAs in our study
were from the community, this is not likely the problem and may
reflect the fact that if the household did not participate, they did
not meet the CTA. However, the CTA was supposed to travel to
the household to offer MDA, and this finding suggests that this was
not always the case. Future MDAs should ensure that in the case of
non-participation the CTA visit the household.
One program feature was related to less accessibility. Commu-
nity treatment assistants living more than one hour from the
Table 5. Multinomial logistic model comparing risk factors for case subgroups with control group.*
All children are cases Some children are cases
Risk factors RRR 95% CI P-value RRR 95% CI P-value
Less able to rely on others for money and shelter
High ability to rely on someone for money and shelter 1.00 1.00
Moderate ability to rely on someone for money and shelter 1.52 (0.75–3.08) 0.25 1.69 (0.94–3.06) 0.08
Low ability to rely on someone for money and shelter 2.11 (0.73–6.06) 0.17 2.11 (0.92–4.82) 0.08
Each one year decrease in guardian age 1.02 (0.98–1.05) 0.33 1.03 (1.00–1.05) 0.03
Guardian’s health is excellent (versus poor/fair) 6.84 (1.90–24.59) ,0.01 3.12 (0.84–11.53) 0.09
Family health burden (versus no burden) 5.23 (1.87–14.65) ,0.01 2.33 (0.74–7.32) 0.15
Each additional child in the household 0.92 (0.62–1.38) 0.69 2.31 (1.86–2.87) ,0.01
Travel time from CTA’s household to furthest household in community
Less than 30 minutes 1.00 1.00
31–60 minutes 1.48 (0.68–3.22) 0.32 1.46 (0.72–2.96) 0.29
More than 60 minutes 1.31 (0.47–3.67) 0.60 4.79 (1.99–11.51) ,0.01
Two (versus five) days distribution 2.03 (1.07–3.85) 0.03 4.29 (2.14–8.60) ,0.01
Less (versus more) than 2 CTAs for 1,000 residents 2.34 (1.11–4.95) 0.03 1.69 (0.89–3.20) 0.11
CTA familiarity
Correctly identified at least one CTA 1.00 1.00
Incorrectly identified CTA 2.15 (1.09–4.26) 0.03 1.88 (1.06–3.34) 0.03
Did not know any CTAs 9.01 (3.33–24.34) ,0.01 3.21 (1.12–9.17) 0.03
CI: Confidence interval.
CTA: Community treatment assistant.
RRR: Relative risk ratio represents the change in the odds of being in the case subgroup versus the control group associated with a one unit change in the independent
variable.
*Relative risk ratios were adjusted for community size and models used robust standard error estimates.
doi:10.1371/journal.pntd.0001576.t005
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persistent child non-participation. Ivermectin MDAs for oncho-
cerciasis also observed further distance from the CTA’s household
to the furthest assigned households was an issue. The CTAs
working within one km were more likely to attain 90% treatment
coverage in the community [27]. With greater travel time in a
community, CTAs have less motivation to return several times to
treat non-respondents, especially if there are only a few in a
household that otherwise participated. This supposition is
supported by our finding that this risk factor is more important
for households where some, but not all, children were persistent
non-participants.
Programs seeking to stop persistent child non-participation
could also address accessibility by increasing the number of
distribution days and improve organization by increasing the
number of CTAs per 1000 residents. In our study, supplemental
treatment distribution days appeared to provide parents with more
flexibility; Guardians could bring their children for treatment on
days that were convenient for them. Past research in child
immunization programs verified that shorter distribution time was
associated with non-participation [28,29]. Modifications in the
schedule allowed more guardians to attend a location, particularly
working mothers. In addition, more assigned CTAs at the central
distribution site cut the treatment lines, helped the drug
administration process run more efficiently, and allowed CTAs
time to visit households on more than one occasion. However, case
and control households both resided in communities that had two
and five days distribution programs so just increasing days alone is
not the only factor. Given that the research provided a small
incentive for CTA time doing MDAs, the cost per additional
coverage needs to be evaluated.
Factors related to the MDA delivery system (good training,
community government support, CTA incentives) are liable to
influence the effectiveness of treatment assistants positively, and
this program contained all of these elements. An experienced non-
government organization, KTP, supervised CTAs during the
course of the MDA through daily observations. Furthermore, the
community leadership recommended and supported CTAs. In
addition, most CTAs were residents in their communities, so other
residents in mass treatment programs would likely be familiar with
their CTAs, even if they did not know they had taken on that
responsibility. Following treatment verification of their work
quality, the program offered CTAs an incentive for completing
high coverage. Thus, we could not measure the effect of lack of
incentives, or CTAs chosen by other mechanisms or lack of
supervision as possible additional program factors.
Increasing distribution time and number of CTAs in programs
alone may not always result in improved performance, as the other
training components for CTAs, CTA incentives, and support from
local community are likely important overall factors as well.
Nevertheless, with such additional factors in mind, programs like
ours that have these elements in place should consider allotting
funds for increased distribution time and more local personnel to
improve participation.
Finally, programs need specific interventions for households
where all children never participated and households where some
children never participated. Our study found each group had
guardians strained in different ways. Strategies for encouraging
households where some children never participated could include
providing CTAs with bikes to travel to families, and working with
local groups to reach out to younger guardians and those with
multiple young children. For households where all children never
participated, CTAs could work with local groups to identify
households with guardians caring for sick family members, develop
a protocol for ‘‘mop-up’’ treatment, and assist these guardians in
getting their children treated. Hiring more than two CTAs for
every 1000 residents may also enable the program to reach
households where children never participated.
Study Strengths
The strengths in this study include minimal misclassification of
cases and controls due to direct observation and recording of
treatment, and the high participation among cases and controls.
Treatment was directly observed by the CTA at the time of
distribution. CTAs were spot-checked by KTP staff during the
implementation of MDA, and treatment verification was carried
out to ensure that records were maintained correctly. Therefore,
we are confident that reporting errors were rare. Community
treatment assistants could have over-reported compliance. How-
ever, treatment verification for the 2008 and 2009 were
exceptional. Our study found misclassification in less than 1% of
households in our study.
We had very high response rate to the survey, 92% case
households and 98% of control households. We found no
differences in any CTA and census characteristics for case
response households and case non-response households. Thus,
we were confident that the risk factors found in our study have
minimal bias due to non-response.
Study Limitations
Case control designs have limitations, notably the problem of
recall bias. We retrospectively collected guardian time-dependent
risk factor data three to six weeks after the 2009 mass treatment.
Data may not be accurate if parents did not recall the information
correctly, such as the state of their health or the other members of
the family. We attempted to improve guardian recall by providing
guardians with the exact dates of mass treatment during the field
interview. Guardians were prompted with the number of weeks
since mass treatment for mass treatment questions in the survey.
Since recall bias might be in any direction it is difficult to predict
how this might impact findings. Second, our study may have
missed additional important factors, especially as related to the
first, 2008, MDA. We did not ask about factors related to the first
MDA as it was over a year ago, but instead factors related to the
second MDA. However, conducting a prospective study, with data
collection immediately prior to each mass treatment, was not
possible.
We also recognize that the non –participation studied here is in
the context of a generally high participation rate using CTA’s that
were motivated and incentivized. Thus, in other settings with
lower coverage or different MDA program design, program
factors may emerge as even more important than what we
observed. Nevertheless, the guardian and program factors we did
find are likely to have good generalizability to other settings similar
to the communities sampled in this study.
Conclusion
Trachoma remains the most common infectious cause of
blindness and is likely to remain so in the near future. Although
treatment participation for trachoma was high in this study, at
both rounds, there were households with children who never
participated. We identified predisposing and resource risk factors
for these households that programs may address with more effort.
Program designs should consider targeting marginalized house-
holds (e.g. multiple children in household, family health burden)
through social mobilization programs. By increasing the number
of distribution days to improve program access and by increasing
the number of treatment assistants to help program organization,
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program may decrease persistent child non-participation. More-
over, partnerships and buy-in with community leadership and
liaison groups will no doubt be vital for the long-term successful
trachoma control program. We dispelled the notion that
households were passive recipients or apathetic non-participants
of mass treatment programs. In actuality, households judge the
treatment’s value and relevance against their children’s needs and
factors related to the guardian, household, and program. In their
design, programs can target these risk factors. The recognition of
risk factors for households with persistent child non-participation is
a critical step for implementing programs encouraging full child
participation over time.
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